Ana Weidenauer
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 06, 2026
Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far.
Journal: Frontiers in psychiatry
Published: December 12, 2025
Understanding patient-reported outcomes in functional movement disorder: Association with clinical measures and change following integrative treatment.
Journal: Journal of psychosomatic research
Published: November 25, 2025
The Role of Fatty Acid Amide Hydrolase, a Key Regulatory Endocannabinoid Enzyme, in Domain-Specific Cognitive Performance in Psychosis.
Journal: Schizophrenia bulletin
Published: December 27, 2024
The role of esketamine in persistent long COVID with predominant psychiatric manifestations.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: December 24, 2024
Impact of Stress on the Endocannabinoid System: A [11C]-CURB Positron Emission Tomography Study in Early Psychosis: Les effets du stress sur le système endocannabinoïde : étude par tomographie par émission de positons avec l'indicateur radioactif [11C-CURB] dans la psychose précoce.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: December 05, 2024
Neural correlates of peripartum depression: a systematic review, meta-analysis and comparison to major depressive disorder.
Journal: Molecular psychiatry
Published: March 06, 2024
The clinical perspective on late-onset depression in European real-world treatment settings.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: November 20, 2023
The relationship between prefrontal cortex gray matter volume and subcortical dopamine release - an addendum.
Journal: Molecular psychiatry
Published: September 05, 2023
The dopaminergic basis of negative symptoms in schizophrenia: an addendum.
Journal: Molecular psychiatry
Published: August 13, 2023
Neurofilament light-chain (NfL) and 18 kDa translocator protein in early psychosis and its putative high-risk.
Journal: Brain, behavior, & immunity - health
Published: June 27, 2023
Last Updated: 09/26/2026